Stand Up to Cancer Overview and Broadcast Reach
Stand Up to Cancer (SU2C) is a program of the Entertainment Industry Foundation that organizes televised fundraising events to accelerate cancer research. The most recent campaign cycle in 2024 raised over $100 million across multiple broadcast and digital platforms, with funds directed to SU2C-funded research teams and clinical trials. SU2C reports that its events have helped generate more than $200 million in total pledges since inception, supporting over 100 active research projects at institutions such as the Stand Up to Cancer-Lustgarten Foundation Pancreatic Cancer Convergence Initiative. Major networks including ABC, NBC, and CBS have carried the primetime specials, which typically feature celebrity hosts, musical performances, and testimonials from patients and researchers. SU2C states that its model emphasizes collaboration among researchers, clinicians, and advocates to speed up the delivery of new therapies to patients.
The 2024 SU2C campaign featured a lineup of performers and hosts drawn from television, film, and music, with the broadcast reaching millions of viewers across the United States. SU2C data indicates that the event generated significant social media engagement, with hashtags related to Stand Up to Cancer trending during the broadcast window. The organization works with production partners and advertisers to fund the event, while the majority of donations go directly to research grants and patient support programs. SU2C also partners with cancer centers and advocacy groups to identify promising early-stage research that can be accelerated through its funding model. The event format combines entertainment segments with updates from SU2C scientific advisors and patient stories to maintain viewer engagement throughout the broadcast.
Key Performers and Hosts in Recent Campaigns
Recent Stand Up to Cancer events have featured performers such as singers, actors, and comedians who volunteer their time for the broadcast. The 2024 lineup included hosts and musical acts drawn from popular television series and award shows, with the goal of maximizing audience reach across demographic groups. SU2C reports that celebrity involvement helps drive donations and awareness, with the broadcast often featuring segments where performers share personal connections to cancer. The organization also highlights researchers and doctors during the event to connect entertainment audiences with the science behind the fundraising efforts.
SU2C's performer roster has historically included a mix of established stars and emerging talent, with casting focused on individuals who can authentically speak to the mission. The 2024 event featured a blend of on-stage performances, pre-taped messages, and live interviews with patients and families affected by cancer. SU2C states that the inclusion of diverse performers helps broaden the event's appeal and supports its goal of reaching new donors. The broadcast structure typically alternates between entertainment segments and educational content about cancer research progress and funding needs.
Fundraising Results and Research Impact
Stand Up to Cancer reports that its 2024 campaign raised more than $100 million through a combination of broadcast donations, online giving, and corporate partnerships. SU2C states that funds are allocated to research teams through a competitive process overseen by its scientific advisory committee, with grants focused on translational research that can move quickly from lab to clinic. The organization has funded over 100 research teams since its founding, with projects spanning immunotherapy, genomics, and early detection technologies. SU2C also tracks the progress of its funded teams and publishes updates on clinical trial milestones and publications.
SU2C's research model emphasizes team science, bringing together investigators from multiple institutions to work on specific cancer types or challenges. The 2024 funding cycle supported projects in pancreatic cancer, blood cancers, and solid tumors, with an emphasis on therapies that could benefit underserved populations. SU2C partners with institutions such as the Lustgarten Foundation and the American Association for Cancer Research to coordinate funding and share data. The organization also provides educational resources for patients and families, connecting them with information about clinical trials and support services through its website and partner networks.